Publications found:
73,128
Sort by:
CD123: a paradigmatic target for immunotherapeutic treatment modalities
US$ 800.00
CD123: a paradigmatic target for immunotherapeutic treatment modalities This report describes and evaluates the competitive landscape of CD123-targeted immunotherapeutics based on different treatment modalities. CD123, or the ... -CD123 Immunotherapeutics Clinical Experience with CD123-Targeted Treatment Modalities Target and Treatment Modality Safety Concerns of anti-CD123 Immunotherapeutics Competitive Landscape Profiles of Anti-CD123 Immunotherapeutics ...
August 2016
83 pages
Regenerative Medicines Market by technology (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules & Biologics), Material (Biodegradable Synthetic Polymers, Scaffold, Hydrogel & Collagen, Transgenic, Fibroblasts, Small Molecules and Biologics) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022
US$ 5,540.00
... in formulating strategic decisions. Regenerative Medicine Market Analysis by Technology On the basis of technology used, this market is segmented into small ... The global regenerative medicine market is segmented based on technology, application and geography. KEY MARKET SEGMENTS MARKET BY TECHNOLOGY Small ...
August 2016
145 pages
Chronic Lymphocytic Leukaemia: KOL Insight
US$ 7,900.00
... treatment landscape? How do key opinion leaders (KOLs) see the future treatment paradigm for chronic lymphocytic leukaemia (CLL) shaping up? Will Gazyva’s/Gazyvaro’s ... reveals candid insights about the CLL landscape from 12 KOLs in North America and Europe. You’ll learn which treatments KOLs consistently ...
August 2016
-
Medical Tourism – a brief guide
US$ 645.00
... models, products and the targeted consumer- and the business of medical tourism for those new to or thinking of entering the market. It offers background ... of medical tourism, this fills the need for an unbiased introduction to the business of medical tourism.” This is not a consumer guide, nor a how to guide, but an overview of medical tourism ...
August 2016
200 pages
Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026
US$ 6,382.00
... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Dry Eye Syndrome’s prevalent population. Identify sub-populations within Dry Eye Syndrome which ...
August 2016
58 pages
MAR T2DM (EU5)
US$ 5,995.00
... in T2DM medical affairs. Can the top two teams hold onto their lead? Two medical affairs teams lead in the EU5 type 2 diabetes mellitus (T2DM) market, but for how long? Competition is fierce ... how your team measures up, in Medical Affairs Reputations: T2DM (EU5). Comparing teams for 12 major T2DM drugs from AstraZeneca, Boehringer Ingelheim, Eli Lilly ...
August 2016
-
MAR T2DM (US)
US$ 5,995.00
... how your team measures up, in Medical Affairs Reputations: T2DM (US). Comparing teams for 11 major T2DM drugs from AstraZeneca, Boehringer Ingelheim, Eli Lilly ... need most? Insights into Medical Affairs Teams for These T2DM Treatments DPP-IV inhibitors: DPP-IV inhibitors Januvia (sitagliptin; Merck & Co.) Tradjenta ...
August 2016
-
Market Access Impact: Multiple Sclerosis (EU5)
US$ 4,995.00
... highly competitive multiple sclerosis (MS) treatment market, prescription barriers helped 6 of the 10 brands we surveyed eke out narrow market ... Exploring Market Access Barriers Market Access Impact: MS explores key issues affecting MS drug manufacturers. You’ll learn: How barriers affect market access: What ...
August 2016
-
Market Access Impact: Multiple Sclerosis (US)
US$ 4,995.00
... highly competitive multiple sclerosis (MS) treatment market, prescription barriers helped 5 of the 10 brands we surveyed eke out narrow market ... Exploring Market Access Barriers Market Access Impact: MS explores key issues affecting MS drug manufacturers. You’ll learn: How barriers affect market access: What ...
August 2016
-
Measuring Marketing Channel Effectiveness
US$ 695.00
... exactly how MCM can be measured effectively and how ROI goals can be achieved. Measuring Marketing Channel Effectiveness: Improving the ROI of Multichannel Marketing makes compelling reading as it reveals insights and the successful strategies used by 13 pharmaceutical marketing experts. Based ...
August 2016
-
NSCLC: KOL Insight
US$ 7,900.00
... CheckMate-026 announcement, provides early KOL insight into the trial’s near-term market impact. Special Feature: KOLs weigh in on CheckMate-026 results ... positive NSCLC Rociletinib (CO-1686; Celgene Corporation/Clovis Oncology) ALK-positive NSCLC Brigatinib (AP26113; ARIAD) ALK and EGFR mutation-negative NSCLC ...
August 2016
-
Patient Assistance Programs
US$ 695.00
Patience Assistance Programmes: Achieving Stakeholder Buy in Patient Assistance Programmes (PAPs) help US patients financially and improve compliance, adherence and outcomes – what’s not to ... off the need for PAPs? Patient Groups: What advantages could Pharma gain by closer collaboration with patient groups in the design and ...
August 2016
-
The Future of Market Access
US$ 695.00
... for Market Access? The profile of Market Access (MA) departments is on the up. No longer simply existing as a ‘bolt on’ for other, more traditional activities, MA is pushing back the marketing boundaries ... Steve Turley, Managing Director, UCB Market Access Expert, European Pharma Company Market Access Expert, European Specialist Pharma Company Market Access Expert, US Pharma Company . ABOUT ...
August 2016
-
Global Sports Medicine Market - Trends and Forecast to 2022
US$ 3,000.00
... development of these products. The Global Sports Medicine Market has been segmented On the basis of product the market is segmented into Orthobiologics, surgical ... & Elbow, Foot & Ankle, and Wrist & Hand. The global sports medicine market is segmented into geographical regions, North & South America, Europe, ...
July 2016
274 pages
Health Information Exchange (HIE) Market Analysis By Setup Type (Private, Public), By Implementation Model (Centralized, Decentralized, Hybrid), By Solution Type (Portal-Centric, Platform-Centric, Messaging-Centric), By Application (Web Portal Development, Internal Interfacing, Workflow Management), And Segment Forecasts To 2024
US$ 5,950.00
The global healthcare information exchange (HIE) market is expected to reach USD 2.21 billion by 2024, according to a new report by Grand ... of colossal amounts of data and facilitated health information exchange, thus the implied demand for the products in the HIE market. In terms of applications, the internal ...
July 2016
92 pages
Global Biopharmaceutical Manufacturing Market Report 2016-2021
US$ 1,799.00
... titled “Global Biopharmaceutical Manufacturing Market Report 2016-2021” provides a detailed analysis on the global biopharmaceutical manufacturing market. Biopharmaceuticals represent one ... of the key companies operating in the global biopharmaceutical manufacturing market such as Pfizer Inc., Roche, Amgen ...
July 2016
110 pages
Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User, Region - Global Forecast to 2021
US$ 3,390.00
... following pointers: Market Penetration: Comprehensive information on product portfolios of top players in the plasma therapy market. The report analyzes the plasma therapy market on the basis of type, source, application ... in the plasma therapy market. Market Development: Comprehensive information about emerging markets; this report analyzes the market for various plasma therapy products across varied geographies. Market Diversification: Exhaustive ...
July 2016
212 pages
European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration
US$ 3,390.00
... in Europe. However, high cost of EDI implementation, lack of infrastructure, and EDI management issues are restrict the overall growth of the market. In this report, the European healthcare EDI market ... insights on the following pointers: Market Penetration: Comprehensive information on players offering EDI solutions in the European healthcare market. The report analyzes the European healthcare EDI market on the basis of transaction ...
July 2016
69 pages
Computerized Physician Order Entry (CPOE) Market Analysis by Type (Standalone, Integrated), by Component (Software, Hardware, Services), by Delivery Mode (On-Premises, Web Based, Cloud Based), by End-Use (Hospital, Ambulatory Centers, Physician’s Office, Emergency Health Services), and Segment Forecasts to 2024
US$ 5,950.00
The global computerized physician/provider order entry (CPOE) market is expected to reach USD 1.9 billion by 2024, according to a new report by ... growth. Further Key Findings from the Study Suggest: The computerized physician order entry (CPOE) services sub-segment dominated the component segment in 2015. ...
July 2016
75 pages
Global Leukemia Therapeutic Market Research and Analysis, 2014-2020
US$ 3,495.00
Market Insight: Global Leukemia Market is expected to exceed $8.6 billion in 2020 with a CAGR 8.8% during 2015-2020. Leukemia is a lingering disease prevalent across ... supportive therapy. COMPETITIVE INSIGHTS: The key players of Leukemia Therapeutic market includes Clavis Pharma ASA, Pfizer, Ambit, Novartis, ...
July 2016
140 pages
Healthcare Analytics Global Market – Forecast To 2022
US$ 4,500.00
... preclusion of chronic diseases, and fraud detection. Global healthcare analytics market is segmented into tool types, applications, components, delivery ... healthcare IT adoption will force this market to emerge into fast growing market in the future. The healthcare analytics market is a fragmented market with ...
July 2016
306 pages
Global Hearing Aids Market by Devices (Behind-The-Ear, In-The-Ear, Receiver-In-The-Ear, Completely-In-The-Canal, In-The-Canal), Implant Types (Cochlear Implant, Bone Anchored Systems), OTC Amplifiers, Diagnostic Instruments, Country Wise Market and Sales Volume Forecast to 2021 and Company Analysis
US$ 1,390.00
... - By Type 3. Global Hearing Aids Market and Forecast - By OTC Amplifiers 4. Global Hearing Aids Market and Forecast - By Diagnostic Instruments 5. Global Hearing Aids Market and Sales Volume - Country Wise Analysis 6. Global Hearing Aids Market - Company Analysis 7. Global Hearing Aids Market - Growth ...
July 2016
151 pages
Human Capital Management Market by Solution (Core HR, Talent Management, Payroll and Tax, Workforce Planning and Analytics, Recruiting), Service (Implementation, Training, Consulting), Deployment, User, Industry Vertical, Region - Global Forecast to 2021
US$ 3,390.00
... market to grow from USD 12.59 billion in 2016 to USD 19.88 billion by 2021, at a CAGR of 9.6%. HCM solutions enable organizations to standardize HR management ... processes, such as talent management, payroll, and workforce planning and analytics. ...
July 2016
174 pages
Market Access Impact - Asthma/COPD (EU5)
US$ 4,995.00
... . This new report from FirstView, Market Access Impact: Asthma/COPD, assesses current barriers and their effects for 12 leading asthma/COPD drugs from GSK, Novartis, AstraZeneca ... Market Access Issues Market Access Impact: Asthma/COPD explores key issues affecting drug manufacturers. You’ll learn: How barriers affect market access: Which brands are physicians prescribing for asthma/COPD ...
July 2016
-
Market Access Impact - Asthma/COPD (US)
US$ 4,995.00
... . This new report from FirstView, Market Access Impact: Asthma/COPD, assesses current barriers and their effects for 12 leading asthma/COPD drugs from GSK, Novartis, AstraZeneca ... Market Access Issues Market Access Impact: Asthma/COPD explores key issues affecting drug manufacturers. You’ll learn: How barriers affect market access: Which brands are physicians prescribing for asthma/COPD ...
July 2016
-
France Hospital Hemostasis Diagnostics Market
US$ 3,120.00
This new report from VPGMarketResearch.com contains 398 pages, 29 tables, and presents a comprehensive analysis of the French hospital hemostasis diagnostic testing market, including:
July 2016
398 pages
France Hospital Hematology and Flow Cytometry Market
US$ 3,080.00
This new report from VPGMarketResearch.com contains 231 pages, 13 tables, and presents a comprehensive analysis of the French hospital hematology and flow cytometry markets, including:
July 2016
231 pages
Germany Hospital Hematology and Flow Cytometry Market
US$ 3,080.00
This new report from VPGMarketResearch.com contains 233 pages, 15 tables, and presents a comprehensive analysis of the German hospital hematology and flow cytometry markets, including:
July 2016
233 pages
Italy Hospital Hematology and Flow Cytometry Market
US$ 3,080.00
This new report from VPGMarketResearch.com contains 233 pages, 15 tables, and presents a comprehensive analysis of the Italian hospital hematology and flow cytometry markets, including:
July 2016
233 pages
Japan Hospital Hematology and Flow Cytometry Market
US$ 3,880.00
This new report from VPGMarketResearch.com contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including:
July 2016
233 pages
Spain Hospital Hematology and Flow Cytometry Market
US$ 3,080.00
This new report from VPGMarketResearch.com contains 236 pages, 15 tables, and presents a comprehensive analysis of the Spanish hospital hematology and flow cytometry markets, including:
July 2016
236 pages
Wearable Devices and IoT in Healthcare 2016 - 2021
US$ 2,995.00
... . Ranging from telemedicine to self-monitoring and diagnosis, wearable devices and the Internet of Things (IoT) will start as a novelty and achieve necessity status ... evaluates the current state of the wearable technology ecosystem including devices, applications, and industry segments. It addresses wearables in consumer and business, key challenges ...
July 2016
201 pages
Digital Health Start Ups
US$ 695.00
... digital health companies were interviewed: Adam Brickman: Director, Strategic Communications and Public Policy, Omada Health Markus Christen: Head of Global Development, Proteus Digital Health ... , Strategic Marketing – mid size pharmaceutical company Director, Digital Health – large pharmaceutical company Director, Digital Health – top 10 pharmaceutical company Senior Vice President – large ...
July 2016
-
Mapping the Patient Journey: Harnessing the power of big data and analytics
US$ 695.00
... finally map the patient journey—developing better, more targeted treatments by knowing when and how to get involved. But companies without the skills to harness ... sometimes millions of patients to understand what's really going on in terms of patient care…” Practical Advice for Harnessing Big Data Breaking down the patient journey: Understand the ...
July 2016
-
Medical Affairs Reputations: Melanoma (EU5)
US$ 5,995.00
... show medical affairs push is paying off for immunotherapies In the EU5 Melanoma treatment market, one brand’s medical affairs team ... Medical Affairs Reputations: Melanoma. Comparing teams for 8 major melanoma drugs head to head, the report reveals how oncologists rate them overall, and on 12 key medical affairs ...
July 2016
-
Medical Affairs Reputations: Melanoma (US)
US$ 5,995.00
... on medical affairs teams for up-to-date information they can use to make better treatment decisions. Does your team deliver? Find out in Medical Affairs Reputations: Melanoma. Comparing teams for 8 major melanoma drugs head to head, the report reveals how oncologists rate them overall, and on 12 key medical affairs services ...
July 2016
-
Multiple Sclerosis: Payer Insight
US$ 7,900.00
... while needs remain unmet. Now payers are fighting back Payers have had it with the high cost of Multiple Sclerosis (MS) drugs and now they ... contain costs. Get the details in Payer Insight: Multiple Sclerosis. You’ll learn what drives treatment costs up, what payers are doing to bring them down, why ...
July 2016
-
NPS+ Growth Hormone Deficiency (GHD) (EU5)
US$ 2,495.00
... satisfied with current growth hormone deficiency treatment options, with only one therapy showing a positive Net Promoter Score (NPS). In the US, GHD brands seem better ... Loyalty Issues NPS+ GHD (EU5) explores key issues affecting brand loyalty for growth hormone manufacturers. You’ll learn: How satisfied the growth hormone market is. How ...
July 2016
-
NPS+ Growth Hormone Deficiency (GHD) (US)
US$ 2,495.00
... boost some GHD brands in the US? Opportunity lurks in the US Growth hormone Deficiency treatment landscape. Although 3 established brands dominate, promoters ... Issues NPS+ GHD (US) explores key issues affecting brand loyalty for growth hormone manufacturers. You’ll learn: How satisfied the growth hormone market ...
July 2016
-
Psoriasis KOL Insight
US$ 7,900.00
... in clinical trials, the report reveals candid insights about the psoriasis landscape from 12 key opinion leaders (KOLs) in North America and Europe. You ... treatments for psoriasis. Find out what they are and how KOLs expect them to influence use. Personalised care is on the horizon: KOLs believe ...
July 2016
-
